Literature DB >> 23961084

Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children.

Mohammed T Tayeb1.   

Abstract

Duchenne and Becker muscular dystrophy (DMD and BMD) are caused, in the majority of cases, by deletions in the dystrophin gene (DMD). The disease is an X-linked neuromuscular diseases typically caused by disrupting (DMD) or non-disrupting (BMD) the reading frame in the dystrophin (DMD) gene. In the present study, amplifications of the genomic DNAs of unrelated 15 Saudi DMD males were carried out using multiplex polymerase chain reaction (PCR) for nine-hotspot regions of exons 4, 8, 12, 17, 19, 44, 45, 48 and 51. We detected six Saudi patients having deletions in a frequency of 40%. The frequency of deletions in exon 51 (20%) was the most common deletion frequently associated with our Saudi sample males. Exons 19, 45, and 48 were present in a frequency of 6.7% each. All deletions were recognized as an individual exonic deletions, while no gross deletion where detected. Finally, the molecular deletions in the Saudi males was expected to be characterized by a moderate frequency among different populations due to the geographical KSA region, which it is in the crossroad of intense migrations and admixture of people coming from continental Asia, Africa, and even Europe. In conclusion, attempts to include an extra DNA samples might reflect a valid vision of the deletions within the high frequency deletion regions (HFDR's) in the DMD gene mutations in KSA.

Entities:  

Keywords:  Deletion mutation; Duchenne muscular dystrophy; Dystrophin gene; Saudi patients

Year:  2010        PMID: 23961084      PMCID: PMC3730798          DOI: 10.1016/j.sjbs.2010.04.008

Source DB:  PubMed          Journal:  Saudi J Biol Sci        ISSN: 1319-562X            Impact factor:   4.219


  28 in total

1.  Becker muscular dystrophy with marked divergence between clinical and molecular genetic findings: case series.

Authors:  G P Ramelli; F Joncourt; J Luetschg; J Weis; M Tolnay; J M Burgunder
Journal:  Swiss Med Wkly       Date:  2006-03-18       Impact factor: 2.193

Review 2.  Genetics of Duchenne muscular dystrophy.

Authors:  R G Worton; M W Thompson
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

Review 3.  Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.

Authors:  Guang-qian Zhou; Hui-qi Xie; Su-zhen Zhang; Zhi-ming Yang
Journal:  Chin Med J (Engl)       Date:  2006-08-20       Impact factor: 2.628

Review 4.  The Duchenne dystrophy story: from phenotype to gene and potential treatment.

Authors:  V Dubowitz
Journal:  J Child Neurol       Date:  1989-10       Impact factor: 1.987

5.  A different spectrum of DMD gene mutations in local Chinese patients with Duchenne/Becker muscular dystrophy.

Authors:  Ivan Fai-man Lo; Kent Keung-san Lai; Tony Ming-for Tong; Stephen Tak-sum Lam
Journal:  Chin Med J (Engl)       Date:  2006-07-05       Impact factor: 2.628

6.  Molecular deletion patterns in Duchenne and Becker muscular dystrophy patients from KwaZulu Natal.

Authors:  K D Hallwirth Pillay; P L A Bill; S Madurai; L Mubaiwa; P Rapiti
Journal:  J Neurol Sci       Date:  2006-12-01       Impact factor: 3.181

7.  More deletions in the 5' region than in the central region of the dystrophin gene were identified among Filipino Duchenne and Becker muscular dystrophy patients.

Authors:  E M Cutiongco; C D Padilla; K Takenaka; Y Yamasaki; M Matsuo; H Nishio
Journal:  Am J Med Genet       Date:  1995-11-06

8.  Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.

Authors:  M Marini; A A Salmi; M S Watihayati; M D SMardziah; M K Zahri; B P Hoh; R Ankathil; P S Lai; B A Zilfalil
Journal:  Med J Malaysia       Date:  2008-03

9.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

10.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

Authors:  A P Monaco; C J Bertelson; S Liechti-Gallati; H Moser; L M Kunkel
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

View more
  2 in total

1.  Effect of Verapamil, an L-Type Calcium Channel Inhibitor, on Caveolin-3 Expression in Septic Mouse Hearts.

Authors:  Bruna A C Rattis; Ana C Freitas; Jordana F Oliveira; João L A Calandrini-Lima; Maria J Figueiredo; Danilo F Soave; Simone G Ramos; Mara R N Celes
Journal:  Oxid Med Cell Longev       Date:  2021-04-08       Impact factor: 6.543

2.  Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.

Authors:  Nasser A Elhawary; Essam H Jiffri; Samira Jambi; Ahmad H Mufti; Anas Dannoun; Hassan Kordi; Asim Khogeer; Osama H Jiffri; Abdelrahman N Elhawary; Mohammed T Tayeb
Journal:  Hum Genomics       Date:  2018-04-10       Impact factor: 4.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.